These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2903542)

  • 21. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy.
    Jones DB; Hunt RH
    Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of endogenous prostaglandins in gastric secretion and mucosal defense.
    Cohen MM
    Clin Invest Med; 1987 May; 10(3):226-31. PubMed ID: 3040310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric ulcers: investigations and treatment.
    Lane MR; Lee SP
    Compr Ther; 1984 Dec; 10(12):24-31. PubMed ID: 6151443
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
    Ivashkin VT; Minasian GA
    Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
    [No Abstract]   [Full Text] [Related]  

  • 26. [Duodenal peptic ulcer. Medical therapy].
    Villalobos Pérez JJ
    Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
    [No Abstract]   [Full Text] [Related]  

  • 27. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peptic ulcer: new aspects of conservative therapy].
    Bernoulli R
    Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peptic ulcer: current therapy].
    Pieragnoli E
    G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
    [No Abstract]   [Full Text] [Related]  

  • 30. Is smoking still important in the pathogenesis of peptic ulcer disease?
    Eastwood GL
    J Clin Gastroenterol; 1997; 25 Suppl 1():S1-7. PubMed ID: 9479620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in ulcer therapy].
    Domschke W
    Fortschr Med; 1983 Apr; 101(13):575-82. PubMed ID: 6133827
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic antagonists to gastric acid secretion.
    Dinoso VP
    Compr Ther; 1978 Jul; 4(7):40-3. PubMed ID: 27329
    [No Abstract]   [Full Text] [Related]  

  • 36. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current trends in medical therapy of gastroduodenal ulcer].
    Grassi M; Fraioli A; Messina B
    Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954
    [No Abstract]   [Full Text] [Related]  

  • 38. Moderate reduction of gastric acid secretion in the treatment of peptic ulcer disease.
    Jaup BH
    Scand J Gastroenterol Suppl; 1985; 111():36-40. PubMed ID: 2861651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerogenic drugs and antiulcer compounds: effects on gastroduodenal mucosa.
    Johansson C
    Scand J Gastroenterol Suppl; 1987; 128():24-32. PubMed ID: 3477002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.